Defilade Capital Management, L.P. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0002088557

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q1 2026 · 31 positions · Total reported value $712.18M · Top-10 concentration 52.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 76.6% · 8 new · 11 cut · 17 exited

Active Share (vs S&P 500): 96.9% · vs QQQ: 97.8% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +0.3% · vs SPY -1.8% · Prev Value $746.95M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +0.1% · vs SPY -2.1% · Latest Value $598.80M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, Defilade Capital Management, L.P. disclosed 31 equity positions with a combined reported value of $712.18M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 52.6% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were ZBH ($52.37M), HSIC ($45.99M), BDX ($43.90M). By sector, the heaviest allocations are Health Care 98.1%, Other 1.9%. Versus the prior quarter, allocation shifted toward Health Care (+1.8pp) and away from Other (-1.8pp).

Versus the prior quarter, Defilade Capital Management, L.P. opened 8 new positions, trimmed 11 and fully exited 17, a turnover rate of 76.6% of positions. The portfolio's overlap with the prior quarter was 52% of names.

The largest new positions opened in Q1 2026 were ZBH ($52.37M), NBIX ($27.66M), PTCT ($25.63M).

Of the 17 positions fully exited versus the prior quarter, the largest were ABBV ($52.02M), NVS ($50.02M), STE ($34.30M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • ZBH ZIMMER BIOMET HOLDINGS INC · $52.37M
  • NBIX NEUROCRINE BIOSCIENCES INC · $27.66M
  • PTCT PTC THERAPEUTICS INC · $25.63M
  • LNTH LANTHEUS HLDGS INC · $18.92M
  • ITGR INTEGER HLDGS CORP · $18.75M
  • TNDM TANDEM DIABETES CARE INC · $14.61M
  • ORIC ORIC PHARMACEUTICALS INC · $10.68M
  • BHVN BIOHAVEN LTD · $2.67M

Fully Exited (vs previous quarter)

  • ABBV ABBVIE INC · prev qtr: $52.02M
  • NVS NOVARTIS AG · prev qtr: $50.02M
  • STE STERIS PLC · prev qtr: $34.30M
  • XNCR XENCOR INC · prev qtr: $21.66M
  • ATRC ATRICURE INC · prev qtr: $15.73M
  • LIVN LIVANOVA PLC · prev qtr: $14.85M
  • ATEC ALPHATEC HLDGS INC · prev qtr: $13.19M
  • GKOS GLAUKOS CORP · prev qtr: $10.35M

Insider Transactions (Form 4)

Latest Defilade Capital Management, L.P. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Defilade Capital Management, L.P. is an SEC-registered 13F filer based in Emeryville, CA, United States. As of Q3 2026 it reported 30 US equity positions with a combined value of $598.80M. HoldingsHub carries 4 quarters of its filings (Q4 2025–Q3 2026).

Firm Snapshot

  • Headquarters: EMERYVILLE, CA, United States
  • SEC registration: 801-134248 (status: Approved), registered 2025-08-27
  • Regulatory AUM (Form ADV): $1.55B as of 2026-06-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: defcap.com

Portfolio Structure

  • 30 positions · $598.80M reported value (Q3 2026)
  • Top 10 holdings = 54.9% of reported value
  • Largest position: PFE (PFIZER INC) at 7.3%
  • Average position size: $19.96M

Sector Tilt

  • Health Care 93.7%
  • Information Technology 3.3%
  • Industrials 3.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 8 new, 9 added, 11 reduced, 17 exited
  • 2 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 98.1%
Other 1.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 579.16K $52.37M 7.35%
7.35%
New
2 624.04K $45.99M 6.46%
6.46%
Add
3 279.21K $43.90M 6.16%
6.16%
Add
4 1.46M $41.11M 5.77%
5.77%
Reduce
5 538.76K $33.83M 4.75%
4.75%
Add
6 254.29K $32.84M 4.61%
4.61%
Reduce
7 194.91K $31.87M 4.47%
4.47%
Add
8 67.68K $31.20M 4.38%
4.38%
Add
9 315.97K $30.73M 4.32%
4.32%
Reduce
10 354.35K $30.53M 4.29%
4.29%
Add
11 209.93K $27.66M 3.88%
3.88%
New
12 1.36M $26.11M 3.67%
3.67%
Add
13 376.17K $25.63M 3.60%
3.60%
New
14 1.50M $22.43M 3.15%
3.15%
Add
15 931.12K $22.28M 3.13%
3.13%
Add
16 604.18K $19.41M 2.73%
2.73%
Reduce
17 20.70K $19.04M 2.67%
2.67%
Reduce
18 249.40K $18.92M 2.66%
2.66%
New
19 213.03K $18.75M 2.63%
2.63%
New
20 96.29K $17.65M 2.48%
2.48%
Reduce
21 678.59K $15.60M 2.19%
2.19%
Add
22 761.90K $14.61M 2.05%
2.05%
New
23 352.59K $13.57M 1.91%
1.91%
Reduce
24 129.95K $13.31M 1.87%
1.87%
Reduce
25 1.49M $12.60M 1.77%
1.77%
Add
26 51.90K $11.87M 1.67%
1.67%
Reduce
27 67.33K $11.54M 1.62%
1.62%
Reduce
28 3.56M $10.98M 1.54%
1.54%
Add
29 842.93K $10.68M 1.50%
1.50%
New
30 315.94K $2.67M 0.38%
0.38%
New
31 7.56M $2.49M 0.35%
0.35%
New

FAQ

What did Defilade Capital Management, L.P. buy in 2026-Q1?

In its 2026-Q1 13F filing, Defilade Capital Management, L.P. reported 31 equity positions worth $712.18M in aggregate; its largest disclosed positions were ZBH ($52.37M), HSIC ($45.99M), BDX ($43.90M).

How large is Defilade Capital Management, L.P.'s portfolio?

Defilade Capital Management, L.P. reported $712.18M of long equity holdings across 31 positions as of 2026-Q1. Top-10 holdings account for 52.6% of reported value.

What is Defilade Capital Management, L.P.'s investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/defilade-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →